CompletedNCT01053429
Official study titlePost-Marketing Surveillance (PMS) Study to Evaluate Safety and Efficacy of Zeldox Capsule
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophrenia, BipolarityObservational study
- Countries
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT01959659
What is this study about?This completed observational study examined healthcare use and the impact of persistent schizophrenia symptoms despite adequately dosed antipsychotic treatment.
This study has finished and is no longer accepting participants.
Multiple locations, including EppingSchizophreniaObservational studyAges 18+
- Countries
- Australia, France, Czechia, + 4 others
- Sponsor
- Hoffmann-La Roche
CompletedNCT03233867
Official study titleA Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity
This study has finished and is no longer accepting participants.
In WayneADHDObservational studyAges 6–17
- Countries
- United States
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
CompletedNCT02811211
Official study titleA Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In WilmingtonADHDObservational studyAges 6–17
- Countries
- United States
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
CompletedACTRN12609000370202
Official study titleA randomised controlled trial to evaluate the effects of D-Cycloserine in combination with Exposure Therapy, versus pill placebo and Exposure Therapy, in the treatment of refractory pediatric Obsessive-Compulsive Disorder (OCD) to improve the severity of obsessive-compulsive (OC) symptoms
This study has finished and is no longer accepting participants.
Location not clearly listedOCDInterventional studyAges 8–17
- Countries
- Sponsor
- Dr Lara Farrell